Recent Posts
- HealthInvest June 2026: A Look Inside Australia’s Healthcare Innovations
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
Archives
Getting the most from your roadshow

Half yearly reporting season for ASX listed companies with a 30 June year end has just finished up. For IR Department, the start of March typically signals the time when our smaller ASX listed company clients would want to roadshow. Some companies, however, will be deliberating over how important roadshows are.
Why M&A is a major investment theme for 2018

Around 22,000 people attended the JP Morgan Healthcare Conference 2018 in San Francisco.
Australian broker Paul Kelly has attended the conference for the past five years. Speaking to Health Invest TV in an interview with IR Department's Managing Director, Jane Lowe, Paul gives you a first-hand account of what happens over the week.
- 1
